Anne Vivian-Scott
Amministratore Delegato presso BKIN Technologies Ltd.
Profilo
Anne Vivian-Scott is currently the President & Chief Executive Officer at BKIN Technologies Ltd.
She previously worked as the Vice President-Commercial Development at PARTEQ Innovations.
Ms. Vivian-Scott completed her undergraduate degree at The University of Waterloo.
Posizioni attive di Anne Vivian-Scott
| Società | Posizione | Inizio |
|---|---|---|
BKIN Technologies Ltd.
 BKIN Technologies Ltd. BiotechnologyHealth Technology BKIN Technologies Ltd. develops robotic technology for sensor motor neuroscience. It allows them to study, with exquisite precision, the sensory, motor and cognitive impact of a wide range of brain injuries and diseases, such as: stroke, cardiac arrest, transient ischemic attack, traumatic brain injury and Parkinson’s disease. The firm products are KINARMA exoskeleton, end point labs, dexterity-E and standard test. The company was founded by Stephen Scott and Ian Brown in 2004 and is headquartered in Kingston, Canada. | Amministratore Delegato | 01/01/2009 |
Precedenti posizioni note di Anne Vivian-Scott
| Società | Posizione | Fine |
|---|---|---|
PARTEQ Innovations
 PARTEQ Innovations Investment ManagersFinance Founded in 1987 by Queen's University at Kingston, Ontario, PARTEQ Innovations is a venture capital firm. | Corporate Officer/Principal | - |
Formazione di Anne Vivian-Scott
| The University of Waterloo | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
PARTEQ Innovations
PARTEQ Innovations Investment ManagersFinance Founded in 1987 by Queen's University at Kingston, Ontario, PARTEQ Innovations is a venture capital firm. | Finance |
BKIN Technologies Ltd.
BKIN Technologies Ltd. BiotechnologyHealth Technology BKIN Technologies Ltd. develops robotic technology for sensor motor neuroscience. It allows them to study, with exquisite precision, the sensory, motor and cognitive impact of a wide range of brain injuries and diseases, such as: stroke, cardiac arrest, transient ischemic attack, traumatic brain injury and Parkinson’s disease. The firm products are KINARMA exoskeleton, end point labs, dexterity-E and standard test. The company was founded by Stephen Scott and Ian Brown in 2004 and is headquartered in Kingston, Canada. | Health Technology |
- Borsa valori
- Insiders
- Anne Vivian-Scott
